Patrick O'Donnell
Direttore/Membro del Consiglio presso CHITOGENX INC.
Patrimonio netto: - $ in data 30/04/2024
Profilo
Patrick T.
O'Donnell is the founder of ProteoThera, Inc. He currently holds the position of President & Chief Executive Officer at HD Lifesciences LLC, is President, Chief Executive Officer & Director at NanoHive Medical LLC, and is an Independent Director at ChitogenX, Inc. In the past, he served as President, Chief Executive Officer & Director at Histogenics Corp., President & Chief Executive Officer at ProChon Biotech Ltd., Director-Global Marketing at Confluent Surgical, Inc., and EVP & GM-Commercial Operations at BONESUPPORT HOLDING AB.
He holds an MBA degree from Dominican University (Illinois) and an undergraduate degree from the University of Wisconsin.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
CHITOGENX INC
-.--% | 09/11/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Posizioni attive di Patrick O'Donnell
Società | Posizione | Inizio |
---|---|---|
CHITOGENX INC. | Direttore/Membro del Consiglio | 24/02/2021 |
HD Lifesciences LLC | Amministratore Delegato | 01/01/2021 |
NanoHive Medical LLC
NanoHive Medical LLC Information Technology ServicesTechnology Services NanoHive Medical LLC is a leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company is based in Woburn, MA. The company's proprietary biomimetic Soft Titanium™ technology sets them apart in the $1.50B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration, all of which lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive was founded by Chris Jones and Ian Helmar, and the CEO is Patrick T. O'Donnell. | Amministratore Delegato | - |
Precedenti posizioni note di Patrick O'Donnell
Società | Posizione | Fine |
---|---|---|
ProChon Biotech Ltd.
ProChon Biotech Ltd. Pharmaceuticals: MajorHealth Technology ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel. | Amministratore Delegato | 01/05/2011 |
Confluent Surgical, Inc.
Confluent Surgical, Inc. Medical SpecialtiesHealth Technology Confluent Surgical, Inc. designed and developed medical devices. The company was founded by Farhad Khosravi in August 1998 and was headquartered in Waltham, MA. | Vendite & Marketing | - |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Amministratore Delegato | - |
BONESUPPORT HOLDING AB | Direttore operativo | - |
OCUGEN, INC. | Presidente | 10/06/2013 |
Formazione di Patrick O'Donnell
Dominican University (Illinois) | Masters Business Admin |
University of Wisconsin | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
BONESUPPORT HOLDING AB | Health Technology |
CHITOGENX INC. | Health Technology |
Aziende private | 6 |
---|---|
Confluent Surgical, Inc.
Confluent Surgical, Inc. Medical SpecialtiesHealth Technology Confluent Surgical, Inc. designed and developed medical devices. The company was founded by Farhad Khosravi in August 1998 and was headquartered in Waltham, MA. | Health Technology |
Histogenics Corp.
Histogenics Corp. BiotechnologyHealth Technology Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA. | Health Technology |
ProChon Biotech Ltd.
ProChon Biotech Ltd. Pharmaceuticals: MajorHealth Technology ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel. | Health Technology |
ProteoThera, Inc.
ProteoThera, Inc. Pharmaceuticals: MajorHealth Technology ProteoThera, Inc. is a biotechnology company that develops drug targeting technology. It offers transformative platform, a proprietary tissue matrix-binding protein fusion technology. The firm develops therapeutics to create a new paradigm in the treatment of auto inflammatory diseases and in tissue regeneration. The company was founded by Jacques P. Moreau, Parth Patwari, and Richard T. Lee and is headquartered in MA. | Health Technology |
HD Lifesciences LLC | |
NanoHive Medical LLC
NanoHive Medical LLC Information Technology ServicesTechnology Services NanoHive Medical LLC is a leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company is based in Woburn, MA. The company's proprietary biomimetic Soft Titanium™ technology sets them apart in the $1.50B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration, all of which lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive was founded by Chris Jones and Ian Helmar, and the CEO is Patrick T. O'Donnell. | Technology Services |
- Borsa valori
- Insiders
- Patrick O'Donnell